Stoke Therapeutics (STOK) Non-cash Items (2018 - 2025)

Stoke Therapeutics has reported Non-cash Items for 8 years, with the latest figure at $184.4 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 802.85% year-over-year to $184.4 million; the trailing twelve-month figure through Dec 2025 stood at $184.4 million (up 802.85% YoY), and the FY2025 full-year result was $184.4 million, up 4199.77% from the prior year.
• Non-cash Items for Q4 2025 stood at $184.4 million, up from $20.4 million in the prior quarter.
• The five-year high for Non-cash Items was $184.4 million in Q4 2025, with the low at $8.4 million in Q4 2023.
• Average Non-cash Items over 5 years is $59.8 million, with a median of $20.6 million recorded in 2022.
• Year-over-year, Non-cash Items tumbled 72.55% in 2021 and surged 802.85% in 2025.
• Tracing STOK's Non-cash Items over 5 years: stood at $65.0 million in 2021, then tumbled by 68.3% to $20.6 million in 2022, then tumbled by 59.05% to $8.4 million in 2023, then jumped by 142.12% to $20.4 million in 2024, then surged by 802.85% to $184.4 million in 2025.
• The last three Non-cash Items figures came in at $184.4 million (Q4 2025), $20.4 million (Q4 2024), and $8.4 million (Q4 2023), per Business Quant data.

Peer Comparison